Dafna Capital Management

Total investments

15

Average round size

44M

Portfolio companies

15

Rounds per year

0.60

Exits

12

Stages of investment
Private Equity
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsGeneticsMedicalNeurosciencePharmaceuticalTherapeuticsBiopharmaClinical Trials

Summary

In 1999 was created Dafna Capital Management, which is appeared as Corporate Investor. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the Los Angeles.

Besides them, we counted 1 critical employee of this fund in our database.

The typical case for the fund is to invest in rounds with 7 participants. Despite the Dafna Capital Management, startups are often financed by Vector Fund Management, New Enterprise Associates, Amerindo Investment Advisors. The meaningful sponsors for the fund in investment in the same round are Iroquois Capital, Perceptive Advisors, New Enterprise Associates. In the next rounds fund is usually obtained by Third Security, Sphera Funds Management, Oxford Finance LLC.

Among the most popular fund investment industries, there are Medical, Pharmaceutical. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Raptor Pharmaceuticals, Cascadian Therapeutics, arGEN-X. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2014. The top activity for fund was in 2010. Comparing to the other companies, this Dafna Capital Management performs on 71 percentage points more the average number of lead investments. The fund is constantly included in less than 2 deals per year.

Show more

Investments analytics

Analytics

Total investments
15
Lead investments
0
Exits
12
Rounds per year
0.60
Investments by industry
  • Biotechnology (15)
  • Health Care (7)
  • Therapeutics (7)
  • Biopharma (6)
  • Pharmaceutical (6)
  • Show 11 more
Investments by region
  • United States (10)
  • Israel (2)
  • Switzerland (1)
  • Netherlands (1)
  • Sweden (1)
Peak activity year
2010
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
100M
Group Appearance index
1.00
Avg. company exit year
23
Avg. multiplicator
2.87

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
DroneInch 01 Feb 2019 Software, Information Technology, SaaS, Robotics, Drones, Drone Management Seed 100K United States, California, Fremont

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.